Evidence map›Paper›PMID 30984326›Full record

ArticleThe Pan African medical journal2019

Burden of measles in Nigeria: a five-year review of casebased surveillance data, 2012-2016.

Baffa Sule Ibrahim, Rabi Usman, Yahaya Mohammed, Zainab Datti, Oyeladun Okunromade, Aisha Ahmed Abubakar, Patrick Mboya Nguku

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Trend of Measles Outbreak in Yemen From January 2020 to August 2024.International journal of general medicine · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Will people in conflict affected zones in Africa have access to COVID-19 vaccine? A case of Nigeria.The International journal of health planning and management · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Baffa Sule IbrahimCenter for International Health, Education and Biosecurity, University of Maryland Baltimore (CIHEB-UMB), Maryland.
Rabi UsmanNigeria Field Epidemiology and Laboratory Training Program, Abuja, Nigeria.
Yahaya MohammedNigeria Field Epidemiology and Laboratory Training Program, Abuja, Nigeria.
Zainab DattiBayero University, Kano, Nigeria.
Oyeladun OkunromadeNigeria Field Epidemiology and Laboratory Training Program, Abuja, Nigeria.
Aisha Ahmed AbubakarAhmadu Bello University, Zaria, Nigeria.
Patrick Mboya NgukuNigeria Field Epidemiology and Laboratory Training Program, Abuja, Nigeria.
African Field Epidemiology Network · NGAhmadu Bello University · NGBayero University Kano · NGUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionmeasles is a vaccine preventable, highly transmissible viral infection that affects mostly children under five years. We reviewed surveillance data on measles from Nigeria over a five-year period to highlights its burden and make recommendations for improvements.

methodswe conducted a secondary data analysis of measles specific Integrated Disease Surveillance and Response (IDSR) records of all states in Nigeria over a five-year period.

resultsa total of 131,732 cases were recorded between January 2012 and September 2016. Most cases 57,892 (43.95%) were recorded in 2013 while the least 11,061 (8.4%) were recorded in 2012. A total of 817 deaths were recorded, with a case fatality rate (CFR) of 0.62%. The highest CFR (1.43%) was recorded in 2012 while the least CFR (0.44%) was recorded in 2016. Only 8,916 (6.7%) cases were confirmed by laboratory tests. The trend of measles cases followed the same pattern throughout the years under review, with cases peaking at March, then gradually reducing to lowest level at June, which was maintained throughout the rest of the year. States in northern region of Nigeria recorded the highest attack rate (Yobe: 480.29 cases per 100,000 population, Sokoto: 284.63 cases per 100,000 population and Katsina: 246.07 cases per 100,000 population) compared to States in the southern region (Rivers: 11.72 cases per 100,000 population and Akwa Ibom: 13.59 cases per 100,000 population). Conversely, States in the southern region recorded the highest CFR (Ebonyi: 13.43% and Rivers: 3.27%).

conclusionmeasles infection remains a burden especially in the northern region of Nigeria. Although measles fatalities declined over the years, laboratory confirmation was sub-optimal. We recommended improvement on routine immunization and strengthening of regional laboratories diagnostic capacities, for successful eradication of measles from Nigeria.

Indexed as

Disease OutbreaksPopulation SurveillanceCost of IllnessHumansMeaslesMeasles VaccineNigeriaRetrospective StudiesVaccinationMeasles VaccineDisease outbreakmeaslesNigeriavaccination

Identifiers

PMID30984326
PMCPMC6445333
OpenAlexW2914329781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.